Article
Downregulated ABCG2 enhances sensitivity to topoisomerase I inhibitor in epidermal growth factor receptor tyrosine kinase inhibitor-resistant non-small cell lung cancer.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer - 1 Nov 2010
Ohtsuka Kouki, Ohnishi Hiroaki, Morii Takeshi, Fujiwara Masachika, Kishino Tomonori, Ogura Wataru, Chiba Misaki, Matsushima Satsuki, Goya Tomoyuki, Watanabe Takashi
Abstract excerpt
INTRODUCTION: Understanding the mechanisms of drug resistance to epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) is essential to develop novel chemotherapies for non-small cell lung cancer (NSCLC). Therefore, we analyzed the expression and function of ATP-binding cassette (ABC) transporters in EGFR TKI-resistant NSCLC. METHODS: In three newly established AG1478-resistant NSCLC cell lines, we...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
